Analysing the entire cohort at baseline, when all patients were affected by a HNSCC, 5 out of 92 proteins had significantly lower means in the p16+ group: PTN, ARG1, CD28, CD70, and TNFRSF 12A. Here, CDKN2A is linked to head and neck squamous cell carcinoma.